Predictors of immune-related adverse events and outcomes in patients with NSCLC treated with immune-checkpoint inhibitors M. Serino; C. Freitas; M. Martins; P. Ferreira; C. Cardoso; F. Veiga; V. Santos; D. Araújo; H. Novais-Bastos; A. Magalhães; H. Queiroga; G. Fernandes; V. Hespanhol;

Feasibility and efficacy of a multidisciplinary palliative approach in patients with advanced interstitial lung disease. A pilot randomised controlled trial I. Bassi; A. Guerrieri; M. Carpano; A. Gardini; I. Prediletto; M. Polastri; J. Randall Curtis; S. Nava;

Endotypes in bronchiectasis: moving towards precision medicine. A narrative review M. Martins; H.R. Keir; J.D. Chalmers;